Clinical implications of dynamic MRI for pituitary adenomas: Clinical and histologic analysis

Journal of Clinical Neuroscience

Volumn 9, Issue 6, 2002, Pages 659-663

  Kanou, Y ^a   Arita, K ^a   Kurisu, K ^a   Tomohide, A ^a   Iida, K ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Dynamic magnetic resonance imaging; Enhancement pattern; Fibrous adenoma; Pituitary adenoma

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 0036853560     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.2002.1141     Document Type: Article

References (22)

1. Hua F, Asato R, Miki Y et al. Differentiation of suprasellar nonneoplastic cysts from cystic neoplasms by Gd-DTPA MRI. J Comput Assist Tomogr 1992; 16: 744-749.
2. Maghnie M, Genovese E, Arico M et al. Evolving pituitary hormone deficiency is associated with pituitary vasculopathy: Dynamic MR study in children with hypopituitarism, diabetes insipidus, and Langerhans cell histiocytosis. Radiology 1994; 193: 493-499.
3. Satoh H, Arita K, Kurisu K, et al. Characteristic imaging findings. Neuroradiology 1996; 38: 328-329.
4. Sato N, Sze G, Endo K. Hypophysitis. Endocrinologic and dynamic MR findings. AJNR 1998; 19: 439-444.
5. Miki Y, Matsuo M, Nishizawa S et al. Pituitary adenoma and normal pituitary tissue: Enhancement patterns on Gadopentetate-enhanced MR imaging. Radiology 1990; 177: 35-38.
6. Sakamoto Y, Takahashik M, Korogi Y, Bussaka H, Ushio Y. Normal and abnormal pituitary glands: Gadopentetate dimeglumine-enhanced MR imaging. Radiology 1991; 178: 723-726.
7. Bonneville JF, Cattin F, Moussa-Bacha K, Portha C. Dynamic computed tomography of the pituitary gland: The "tuft sign". Radiology 1983; 149: 145-148.
8. Finelli DA, Kaufman B. Varied microcirculation of pituitary adenoma at rapid, dynamic, contrast-enhanced MR imaging. Radiology 1993; 189: 205-210.
9. Doppman JL, Frank JA, Dwyer AJ et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 1988; 12: 728-735.
10. Dwyer AJ, Frank JA, Doppman JL et al. Pituitary adenomas in patients with Cushing disease: Initial experience with Gd-DTPA-enhanced MR imaging. Radiology 1987; 163: 421-426.
11. Newton DR, Dillon WP, Norman D, Newton TH, Wilson CB. Gd-DTPA-enhanced MR imaging of pituitary adenomas. AJNR 1999; 10: 949-954.
12. Stadnik T, Stevenaert A, Beckers A, Luypaert R, Buisseret T, Osteaux M. Pituitary microadenomas: Diagnosis with two- and three-dimensional MR imaging at 1.5T before and after injection of gadolinium. Radiology 1990; 176:419-428.
13. Bartynski WS, Lin L. Dynamic and conventional spin-echo MR ofpituitary microlesions. AJNR 1997; 18: 965-972.
14. Kucharczyk W, Bishop JE, Plewes DB, Keller MA, George S. Detection of pituitary microadenomas: Comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging. AJR 1994; 163: 671-679.
15. Tabarin A, Laurent F, Catargi B et al. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease. Clin Endocrinol (Oxf) 1998; 49: 293-300.
16. Tien RD. Sequence of enhancement of various portions of the pituitary gland on gadolinium-enhanced MR images: Correlation with regional blood supply. AJR 1992; 158: 651-654.
17. Bonneville JF, Cattin F, Gorczyca W. Pituitary micro adenomas: Early enhancement with dynamic CT: Implications of arterial blood supply and potential importance. Radiology 1993; 187: 857-861.
18. Yuh WTC, Fisher DJ, Nguyen HD et al. Sequential enhancement pattern in normal pituitary gland and in pituitary adenoma. AJNR 1994; 15: 101-108.
19. Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: Animal studies using gadolinium-DTPA complex. AJR 1984; 142:625-630.
20. Strich G, Hagan PL, Gerber KH, Slutsky RA. Tissue distribution and magnetic resonance spin lattice relaxation effects of Gadolinium-DTPA. Radiology 1985; 154: 857-861.
21. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of Gadolinium-DTPA complex: A potential NMR contrast agent. AJR 1984; 142:619-624.
22. Hirano A, Tomiyasu U, Zimmerman HM. The fine structure of blood vessels in chromophobe adenoma. Acta Neuropath (Berl) 1972; 22: 200-207.